Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Inspire discontinues development of denufosol tetrasodium for retinal diseases

Jan. 25, 2006

Recent patent discloses novel therapeutic agents for ocular disorders

Jan. 20, 2006

Positive toxicology data for Binoxan active ingredient

Jan. 20, 2006

Pegaptanib binding analyzed, revealing mechanism of action

Jan. 19, 2006

Lucentis maintained or improved vision in approximately 95% of patients at one year

Jan. 17, 2006

Lantibio and TRB Chemedica sign agreement for Vismed

Jan. 17, 2006

Novagali completes phase II study of ophthalmic formulation of ciclosporin

Jan. 17, 2006

Vitragan MAA accepted for review

Jan. 13, 2006

PR Pharmaceuticals and OSI collaborate on sustained-release Macugen

Jan. 13, 2006

iDESTRIN relieves signs and symptoms of dry eye syndrome in postmenopausal women

Jan. 10, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 28, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 28, 2026.
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...